Because it sounds so obviously logical, policymakers and payers have been quick to adopt and enforce various pay-for-performance and quality reporting schemes, often ignoring warnings about design and operational issues. A report from the Urban Institute details concerns about such programs and offers suggestions for a path to improving them. (Urban Inst. Report) The goal of quality reporting and incentive programs is quality improvement, yet the evaluations of most of these programs show very little if any progress on that goal to date. This may be because the programs tend to focus on process measures which may have little to do with real health outcomes, but are easier to collect data on. One big problem with these programs is that they are disruptive and expensive to comply with, and they may hinder a clinician’s sense of autonomy and motivation. The authors detail the problems and concerns and then give seven well-thought out recommendations for improving quality reporting, pay-for-performance and value-based purchasing programs: move from measuring process to directly measuring outcomes; don’t rely solely on these programs for quality improvement but use them only where other approaches may not work; measure quality at an organizational level, not that of the individual clinician; measure patient experience and patient-reported outcomes as their own ends; promote rapid-learning through the programs; develop the science of measurement better, especially to avoid unintended consequences; and have only one entity developing measures and standards.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
April 19, 2024
Another Body Blow to Gender Dis-Affirmation
A review from Britain reveals the complete lack of any scientific evidence to support the…
Commentary
April 18, 2024
Progress Against Cancer
The US has made particularly good progress in treating cancer and limiting mortality, but much…
Commentary
April 17, 2024
I Am Done With Coronamonomania, Part 4, Vax Safety Edition
A somewhat lengthy examination of recent studies related mostly to vax safety, the results of…